CME Group posts record Q3 revenue: CME gains momentum

Traders Union
All News
Stocks
CME Group jumps 3.01% to $305

Highlights

CME Group reported record revenue for the third quarter, supporting views of stronger top-line growth and solid operations.
The lack of specific financial figures did not deter increased investor demand for shares of CME Group.
CME stock trades in a positive short- and medium-term trend with support at 299.73 and an expected range of 297.36 to 314.09 for the next 2 to 3 days.

Earnings optimism rises as record Q3 revenue attracts buyers

CME Group has reported record Q3 revenue, a development that signals higher top-line growth and robust operational results, according to Wealthawesome. Although the report did not disclose specific revenue figures or earnings data, the announcement alone has fueled expectations of improved earnings quality. This backdrop helps explain the current uptick in investor demand for CME shares.

Mixed momentum signals as overbought conditions meet strong demand

On the h1 timeframe, CME trades above its MA-20 and MA-50, while on the daily chart, it remains comfortably over the MA-200. Immediate support is marked by the Ichimoku Kijun at $299.73. MACD is neutral, and Awesome Oscillator shows no clear direction, while ADX generates a Buy signal, suggesting momentum is present but not fully confirmed by all indicators. RSI stands at 64.22, indicating a buy bias, though both Stochastic RSI and CCI are overbought, hinting at possible exhaustion. Bull/Bear Power remains strong, indicating evident buyer dominance during the session.

Bullish bias favored as short-term consolidation expected

In the next 2–3 trading days, CME is expected to trade within the $297.36–$314.09 range. With a 79% probability of further upside and only 21% chance of a downward move, the outlook leans bullish. The baseline scenario points to consolidation inside the current range. A bullish breakout could see CME test the upper band, while a drop below support would likely challenge lower levels of the forecast corridor.

Viktoras Karapetjanc, Traders Union expert, views CME Group's breakout on robust Q3 revenue as a strong fundamental tailwind. The analyst notes active buying momentum and clear technical support, despite some signs of short-term exhaustion. Macro sentiment remains positive, with the market focusing on top-line growth and earnings expectations. Karapetjanc believes further upside is likely within the current range. "I see the record revenue announcement as a catalyst for continued near-term strength, making CME an attractive play for bullish investors right now."

Previously it was reported that analysts saw near-term selling pressure for CME Group despite favorable long-term fundamentals and capital returns. The latest technical readings and improved operational outlook now indicate a bullish trend, with traders advised to monitor for a potential breakout above the upper bound of the current $297.36–$314.09 forecast range.

Source of Data: CME Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

The information is based on forecasts and does not constitute investment advice or a guarantee of future results. Market conditions may change. See our Disclaimer and Editorial Integrity for details.